As a leading reference on pediatric cardiology and congenital heart disease, Anderson's Pediatric Cardiology provides exhaustive coverage of potential pediatric cardiovascular anomalies, potential sequelae related to these anomalies, comorbidities and neurodevelopmental problems, and current methods for management and treatment. The fully revised 4th Edition addresses significant and ongoing changes in practice, including recent developments in fetal, neonatal, and adult congenital heart conditions as well as expanded content on intensive care, nursing issues, and societal implications. The outstanding illustration program provides superb visual guidance, and is now supplemented with a remarkable collection of more than 200 professionally curated, author-narrated videos.
1. Introduction - p. 335 2. Bradyarrhythmias - p. 335 3. Syncope - p. 340 4. Tachyarrhythmias - p. 341 5. Supraventricular Arrhythmias - p. 341 6. Ventricular Arrhythmias - p. 350 7. Channelopathies - p. 351 8. Arrhythmias in Adults With Congenital Heart Disease - p. 356 9. Electrophysiologic Testing - p. 357 10. Pacemakers and Defibrillators - p. 364 11. Implantable Cardioverter/Defibrillators - p. 366 12. Cardiac Resynchronization Therapy - p. 367 13. Pacemaker Function and Follow-up - p. 368 14. Arrhythmias Following Congenital Heart Disease Surgery - p. 374 15. Annotated References - p. 378.e1 16. References - p. 378.e1 17. 23 Cardiopulmonary Exercise Testing - p. 379 18. 24 Pediatric Cardiovascular Data, Analysis, and Critical Appraisal of the Literature - p. 403 19. 25 Cardiovascular Risk Factors in Youth - p. 423 20. Section 4 Specific Lesions - p. 437.e7 21. 26 Isomerism of the Atrial Appendages - p. 441 22. 27 Anomalous Systemic Venous Return - p. 457 23. 28 Pulmonary Venous Abnormalities - p. 475 24. 29 Interatrial Communications - p. 503 25. 30 Division of Atrial Chambers (“Cor Triatriatum”) - p. 517 26. 31 Atrioventricular Septal Defects - p. 521 27. 32 Ventricular Septal Defect - p. 555 28. 33 Diseases of the Tricuspid Valve - p. 585 29. 34 Diseases of the Mitral Valve - p. 607 30. 35 Tetralogy of Fallot With Pulmonary Stenosis - p. 631 31. 36 Tetralogy of Fallot With Pulmonary Atresia - p. 653 32. 37 Transposition - p. 675 33. 38 Congenitally Corrected Transposition - p. 697 34. 39 Double-Outlet Ventricle - p. 715 35. 40 Common Arterial Trunk - p. 741 36. 41 Arterial Duct - p. 755 37. 42 Pulmonary Stenosis - p. 775 38. 43 Pulmonary Atresia With Intact Ventricular Septum - p. 803 39. 44 Congenital Anomalies of the Aortic Valve and Left Ventricular Outflow Tract - p. 819 40. 45 Coarctation and Interrupted Aortic Arch - p. 843 41. 46 Congenital Coronary Anomalies - p. 865 42. 47 Vascular Rings, Pulmonary Arterial Sling, and Related Conditions - p. 877 43. 48 Artery of the Fifth Aortic Arch - p. 901 44. 49 Abnormal Positions and Relationships of the Heart - p. 913 45. 50 Arteriovenous Communications - p. 927 46. 51 Other Malformations of the Ventricular Outflow Tracts - p. 945 47. 52 Cardiac Tumors - p. 963 48. 53 Kawasaki Disease - p. 979 49. 54 Acute Rheumatic Fever - p. 997 50. 55 Chronic Rheumatic Heart Disease - p. 1023 51. 56 Infective Endocarditis - p. 1043 52. 57 Pericardial Diseases in Children - p. 1063 53. 58 Aortopathies in Pediatric Cardiology and Cardiac Surgery - p. 1077 54. 59 Cardiologic Aspects of Systemic Disease - p. 1087 55. Abstract - p. 1087 56. Metabolic Disorders: Storage Diseases - p. 1087 57. Endocrine Disorders - p. 1095 58. Disorders of Energy Metabolism - p. 1097 59. Disorders of Collagen Synthesis or Extracellular Matrix - p. 1098 60. Neuromuscular Diseases - p. 1102 61. Nutritional Deficiencies - p. 1107 62. Deposition Diseases - p. 1108 63. Autoimmune Diseases - p. 1109 64. Heart Disease Induced by Toxins - p. 1111 65. Miscellaneous Systemic Disorders - p. 1112 66. Summary - p. 1113 67. Annotated References - p. 1113.e1 68. References - p. 1113.e1 69. 60 Systemic Hypertension - p. 1115 70. Abstract - p. 1115 71. Introduction - p. 1115 72. Evaluation of Blood Pressure: Measurement, Normal Values, and Important Influences - p. 1115 73. Hypertension - p. 1124 74. Medical Therapy - p. 1139 75. References - p. 1142.e1 76. Section 5 Heart Failure and Transplantation - p. 1142.e8 77. 61 Cardiomyopathies - p. 1145 78. 62 Cardio-oncology - p. 1167 79. 63 Myocarditis - p. 1173 80. 64 Acute Circulatory Failure - p. 1179 81. 65 Chronic Heart Failure - p. 1193 82. 66 Chronic Mechanical Circulatory Support - p. 1205 83. 67 Heart and Heart-Lung Transplantation - p. 1217 84. Section 6 Functionally Univentricular Heart - p. 1239.e3 85. 68 Introduction - p. 1243 86. 69 Anatomic Considerations in the Functionally Univentricular Heart - p. 1245 87. 70 Physiologic Principles to Maximize Outcome in Patients With a Functionally Univentricular Heart - p. 1261 88. 71 Fontan Pathway From Birth Through Early Childhood - p. 1273 89. Abstract - p. 1273 90. Introduction - p. 1273 91. Neonatal Stabilization, Surgical Strategies, and Postoperative Management - p. 1273 92. Second-Stage Palliation: The Superior Cavopulmonary Connection - p. 1296 93. Third-Stage Reconstruction: The Modified Fontan Procedure - p. 1300 94. Outcomes Along the Fontan Pathway - p. 1304 95. Future Considerations - p. 1305 96. Closing Thoughts - p. 1306 97. Annotated References - p. 1306.e1 98. References - p. 1306.e1 99. 72 Interstage Management - p. 1307 100. 73 Longer-Term Outcomes and Management for Patients With a Functionally Univentricular Heart - p. 1317 101. Abstract - p. 1317 102. Evolution of the Fontan Procedure - p. 1317 103. Late Outcome With a Fontan Circulation - p. 1317 104. Late Predictors - p. 1320 105. Consequences of the Fontan Circulation - p. 1320 106. Impaired Exercise Capacity (see also Chapter 23) - p. 1321 107. Arrhythmia (see also Chapter 22) - p. 1324 108. Summary - p. 1329 109. Hematologic and Immunologic Complications - p. 1329 110. Fontan-Associated Liver Disease - p. 1331 111. Neurocognitive and Psychosocial Function - p. 1334 112. Management of the “Well” Fontan - p. 1336 113. Cardiac Catheterization and Transcatheter Intervention - p. 1340 114. Management of Fontan Failure - p. 1342 115. Future Directions - p. 1348 116. Annotated References - p. 1351.e1 117. References - p. 1351.e1 118. Section 7 Beyond the Heart - p. 1351.e10 119. 74 Systemic Circulation - p. 1355 120. Abstract - p. 1355 121. Introduction - p. 1355 122. Systemic Arterial System - p. 1355 123. Modeling of the Systemic Circulation - p. 1359 124. Measurement of Arterial Function - p. 1362 125. Systemic Arterial Dysfunction in Childhood - p. 1370 126. Ventriculoarterial Interaction - p. 1375 127. The Future - p. 1379 128. Annonated References - p. 1379.e1 129. References - p. 1379.e1 130. 75 Pulmonary Hypertension - p. 1381 131. 76 Neurodevelopmental and Psychosocial Outcomes in Children and Young Adults With Complex Congenital Cardiac Disease - p. 1393 132. 77 Congenital Cardiac Disease in the Setting of Genetic Syndromes - p. 1407 133. 78 Acute and Chronic Renal Consequences of Cardiac Disease in Children - p. 1421 134. 79 Pharmacogenetics in the Treatment of Congenital and Acquired Cardiac Disease During Childhood - p. 1429 135. 80 Pregnancy and Congenital Heart Disease - p. 1441 136. 81 Preparing the Young Adult With Complex Congenital Cardiac Disease to Transfer From Pediatric to Adult Care - p. 1451 137. 82 Psychological and Social Aspects of Pediatric Cardiac Disease - p. 1455 138. 83 Ethical Issues in Pediatric Cardiology and Congenital Heart Disease - p. 1465 139. 84 Clinical Care Pathways Supporting the Care of Children and Young People With Congenital Heart Disease - p. 1481 140. 85 Discharge Planning, Communications With the Team Providing Care in the Ambulatory Setting and the “Medical Home” - p. 1487 141. 86 Growth and Nutrition - p. 1495 142. 87 Quality Improvement in Congenital Cardiac Disease - p. 1505 143. 88 Global Burden of Pediatric Heart Disease and Pediatric Cardiac Care in Low- and Middle-Income Countries - p. 1519 144. 89 Screening in Pediatric and Congenital Cardiac Disease - p. 1535 145. 90 Anesthetic Considerations for Cardiac and Noncardiac Surgery in the Child With Congenital Cardiac Disease - p. 1547 146. 91 Telemedicine in Pediatric Cardiology - p. 1553 147. Index - p. 1561
As a leading reference on pediatric cardiology and congenital heart disease, Anderson's Pediatric Cardiology provides exhaustive coverage of potential pediatric cardiovascular anomalies, potential sequelae related to these anomalies, comorbidities and neurodevelopmental problems, and current methods for management and treatment. The fully revised 4th Edition addresses significant and ongoing changes in practice, including recent developments in fetal, neonatal, and adult congenital heart conditions as well as expanded content on intensive care, nursing issues, and societal implications. The outstanding illustration program provides superb visual guidance, and is now supplemented with a remarkable collection of more than 200 professionally curated, author-narrated videos.
1. Introduction - p. 335 2. Bradyarrhythmias - p. 335 3. Syncope - p. 340 4. Tachyarrhythmias - p. 341 5. Supraventricular Arrhythmias - p. 341 6. Ventricular Arrhythmias - p. 350 7. Channelopathies - p. 351 8. Arrhythmias in Adults With Congenital Heart Disease - p. 356 9. Electrophysiologic Testing - p. 357 10. Pacemakers and Defibrillators - p. 364 11. Implantable Cardioverter/Defibrillators - p. 366 12. Cardiac Resynchronization Therapy - p. 367 13. Pacemaker Function and Follow-up - p. 368 14. Arrhythmias Following Congenital Heart Disease Surgery - p. 374 15. Annotated References - p. 378.e1 16. References - p. 378.e1 17. 23 Cardiopulmonary Exercise Testing - p. 379 18. 24 Pediatric Cardiovascular Data, Analysis, and Critical Appraisal of the Literature - p. 403 19. 25 Cardiovascular Risk Factors in Youth - p. 423 20. Section 4 Specific Lesions - p. 437.e7 21. 26 Isomerism of the Atrial Appendages - p. 441 22. 27 Anomalous Systemic Venous Return - p. 457 23. 28 Pulmonary Venous Abnormalities - p. 475 24. 29 Interatrial Communications - p. 503 25. 30 Division of Atrial Chambers (“Cor Triatriatum”) - p. 517 26. 31 Atrioventricular Septal Defects - p. 521 27. 32 Ventricular Septal Defect - p. 555 28. 33 Diseases of the Tricuspid Valve - p. 585 29. 34 Diseases of the Mitral Valve - p. 607 30. 35 Tetralogy of Fallot With Pulmonary Stenosis - p. 631 31. 36 Tetralogy of Fallot With Pulmonary Atresia - p. 653 32. 37 Transposition - p. 675 33. 38 Congenitally Corrected Transposition - p. 697 34. 39 Double-Outlet Ventricle - p. 715 35. 40 Common Arterial Trunk - p. 741 36. 41 Arterial Duct - p. 755 37. 42 Pulmonary Stenosis - p. 775 38. 43 Pulmonary Atresia With Intact Ventricular Septum - p. 803 39. 44 Congenital Anomalies of the Aortic Valve and Left Ventricular Outflow Tract - p. 819 40. 45 Coarctation and Interrupted Aortic Arch - p. 843 41. 46 Congenital Coronary Anomalies - p. 865 42. 47 Vascular Rings, Pulmonary Arterial Sling, and Related Conditions - p. 877 43. 48 Artery of the Fifth Aortic Arch - p. 901 44. 49 Abnormal Positions and Relationships of the Heart - p. 913 45. 50 Arteriovenous Communications - p. 927 46. 51 Other Malformations of the Ventricular Outflow Tracts - p. 945 47. 52 Cardiac Tumors - p. 963 48. 53 Kawasaki Disease - p. 979 49. 54 Acute Rheumatic Fever - p. 997 50. 55 Chronic Rheumatic Heart Disease - p. 1023 51. 56 Infective Endocarditis - p. 1043 52. 57 Pericardial Diseases in Children - p. 1063 53. 58 Aortopathies in Pediatric Cardiology and Cardiac Surgery - p. 1077 54. 59 Cardiologic Aspects of Systemic Disease - p. 1087 55. Abstract - p. 1087 56. Metabolic Disorders: Storage Diseases - p. 1087 57. Endocrine Disorders - p. 1095 58. Disorders of Energy Metabolism - p. 1097 59. Disorders of Collagen Synthesis or Extracellular Matrix - p. 1098 60. Neuromuscular Diseases - p. 1102 61. Nutritional Deficiencies - p. 1107 62. Deposition Diseases - p. 1108 63. Autoimmune Diseases - p. 1109 64. Heart Disease Induced by Toxins - p. 1111 65. Miscellaneous Systemic Disorders - p. 1112 66. Summary - p. 1113 67. Annotated References - p. 1113.e1 68. References - p. 1113.e1 69. 60 Systemic Hypertension - p. 1115 70. Abstract - p. 1115 71. Introduction - p. 1115 72. Evaluation of Blood Pressure: Measurement, Normal Values, and Important Influences - p. 1115 73. Hypertension - p. 1124 74. Medical Therapy - p. 1139 75. References - p. 1142.e1 76. Section 5 Heart Failure and Transplantation - p. 1142.e8 77. 61 Cardiomyopathies - p. 1145 78. 62 Cardio-oncology - p. 1167 79. 63 Myocarditis - p. 1173 80. 64 Acute Circulatory Failure - p. 1179 81. 65 Chronic Heart Failure - p. 1193 82. 66 Chronic Mechanical Circulatory Support - p. 1205 83. 67 Heart and Heart-Lung Transplantation - p. 1217 84. Section 6 Functionally Univentricular Heart - p. 1239.e3 85. 68 Introduction - p. 1243 86. 69 Anatomic Considerations in the Functionally Univentricular Heart - p. 1245 87. 70 Physiologic Principles to Maximize Outcome in Patients With a Functionally Univentricular Heart - p. 1261 88. 71 Fontan Pathway From Birth Through Early Childhood - p. 1273 89. Abstract - p. 1273 90. Introduction - p. 1273 91. Neonatal Stabilization, Surgical Strategies, and Postoperative Management - p. 1273 92. Second-Stage Palliation: The Superior Cavopulmonary Connection - p. 1296 93. Third-Stage Reconstruction: The Modified Fontan Procedure - p. 1300 94. Outcomes Along the Fontan Pathway - p. 1304 95. Future Considerations - p. 1305 96. Closing Thoughts - p. 1306 97. Annotated References - p. 1306.e1 98. References - p. 1306.e1 99. 72 Interstage Management - p. 1307 100. 73 Longer-Term Outcomes and Management for Patients With a Functionally Univentricular Heart - p. 1317 101. Abstract - p. 1317 102. Evolution of the Fontan Procedure - p. 1317 103. Late Outcome With a Fontan Circulation - p. 1317 104. Late Predictors - p. 1320 105. Consequences of the Fontan Circulation - p. 1320 106. Impaired Exercise Capacity (see also Chapter 23) - p. 1321 107. Arrhythmia (see also Chapter 22) - p. 1324 108. Summary - p. 1329 109. Hematologic and Immunologic Complications - p. 1329 110. Fontan-Associated Liver Disease - p. 1331 111. Neurocognitive and Psychosocial Function - p. 1334 112. Management of the “Well” Fontan - p. 1336 113. Cardiac Catheterization and Transcatheter Intervention - p. 1340 114. Management of Fontan Failure - p. 1342 115. Future Directions - p. 1348 116. Annotated References - p. 1351.e1 117. References - p. 1351.e1 118. Section 7 Beyond the Heart - p. 1351.e10 119. 74 Systemic Circulation - p. 1355 120. Abstract - p. 1355 121. Introduction - p. 1355 122. Systemic Arterial System - p. 1355 123. Modeling of the Systemic Circulation - p. 1359 124. Measurement of Arterial Function - p. 1362 125. Systemic Arterial Dysfunction in Childhood - p. 1370 126. Ventriculoarterial Interaction - p. 1375 127. The Future - p. 1379 128. Annonated References - p. 1379.e1 129. References - p. 1379.e1 130. 75 Pulmonary Hypertension - p. 1381 131. 76 Neurodevelopmental and Psychosocial Outcomes in Children and Young Adults With Complex Congenital Cardiac Disease - p. 1393 132. 77 Congenital Cardiac Disease in the Setting of Genetic Syndromes - p. 1407 133. 78 Acute and Chronic Renal Consequences of Cardiac Disease in Children - p. 1421 134. 79 Pharmacogenetics in the Treatment of Congenital and Acquired Cardiac Disease During Childhood - p. 1429 135. 80 Pregnancy and Congenital Heart Disease - p. 1441 136. 81 Preparing the Young Adult With Complex Congenital Cardiac Disease to Transfer From Pediatric to Adult Care - p. 1451 137. 82 Psychological and Social Aspects of Pediatric Cardiac Disease - p. 1455 138. 83 Ethical Issues in Pediatric Cardiology and Congenital Heart Disease - p. 1465 139. 84 Clinical Care Pathways Supporting the Care of Children and Young People With Congenital Heart Disease - p. 1481 140. 85 Discharge Planning, Communications With the Team Providing Care in the Ambulatory Setting and the “Medical Home” - p. 1487 141. 86 Growth and Nutrition - p. 1495 142. 87 Quality Improvement in Congenital Cardiac Disease - p. 1505 143. 88 Global Burden of Pediatric Heart Disease and Pediatric Cardiac Care in Low- and Middle-Income Countries - p. 1519 144. 89 Screening in Pediatric and Congenital Cardiac Disease - p. 1535 145. 90 Anesthetic Considerations for Cardiac and Noncardiac Surgery in the Child With Congenital Cardiac Disease - p. 1547 146. 91 Telemedicine in Pediatric Cardiology - p. 1553 147. Index - p. 1561
